PPARGC1A and Alzheimer disease: Furthermore, preclinical studies show that treatment with NR reduces the formation of amyloid plaques, improves contextual memory and cognitive function, and attenuates synaptic plasticity by promoting PGC-1α-mediated β-secretase degradation, which prevents the production of Aβ in the brain of transgenic AD mouse models [68,91].